Samaneh Yazdi - Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Majid Darroudi - Nuclear Medicine Research Center, Department of Modern Science and Technology, Mashhad University of Medical Sciences, Mashhad, Iran
Armin Imanparast - mashhad university of medical science,medical physics department
Fatemeh Hataminia - Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Introduction: The most important limitation of 5-aminolevulinic acid (5-ALA)-induced photodynamic therapy (PDT) is the efficacy of the cells in converting 5-ALA to protoporphyrin IX. The present study aimed to investigate the effectiveness of silver nanoparticles (AgNPs) with the photosensitivity at the surface plasmon resonance wavelength on 5-ALA-mediated PDT. Material and Methods: First of all, the toxicity of 5-ALA, AgNPs, and combined 5-ALA and AgNPs was evaluated on DFW cell line derived from melanoma. After choosing the optimal concentration, both pulsed and continuous light irradiations were conducted at different doses using a light‑emitting diode source in the groups receiving 5-ALA, AgNPs, as well as 5-ALA and AgNPs combination, and the controls. The cell survival was evaluated 24 h after irradiation using MTT assay. Results: According to the results, light exposure did not significantly change cell survival in the absence or presence of AgNPs. However, light exposure in the presence of 5-ALA and AgNPs/5-ALA combination caused a significant reduction in the cell survival. The necessary light exposure to induce 50% cell death (ED50) in the presence of 5-ALA was 1280 mJ/cm2; however, this value was 280 mJ /cm2 in the presence of combined AgNPs and 5-ALA. Conclusion: As the findings indicated, PDT had a higher efficacy in the presence of combined 5-ALA and AgNPs than in the sole 5-ALA presence. Nonetheless, further studies are required to evaluate the definitive mechanism of these findings. 

Photodynamic Therapy, Nanoparticle, 5-Aminolevolinic Acid, DFW Cell Line, Protoporphyrin IX